| Ryan C O'connor, DO | |
|
4660 S Hagadorn Rd Ste 520, East Lansing, MI 48823-6804 | |
| (517) 884-8701 | |
| (517) 884-8787 |
| Full Name | Ryan C O'connor |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 25 Years |
| Location | 4660 S Hagadorn Rd Ste 520, East Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194714691 | NPI | - | NPPES |
| 1194714691 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 5101014205 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mclaren Greater Lansing | Lansing, MI | Hospital |
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Msu Health Care Inc. | 8628404936 | 202 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
Hundreds of dogs are hit with dog flu over the last couple of years. In a new development, this flu strain has hit Florida for the first time. At least a dozen dogs have been down with the virus according to a report issued by the University of Florida's College of Veterinary Medicine on the 31st of May 2017.
Doctors have been given permission to assist two women in becoming pregnant with "three-person" babies for the first time in the UK.
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
› Verified 2 days ago
| Entity Name | Michigan State University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861443269 PECOS PAC ID: 3870405954 Enrollment ID: O20031105000741 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
Hundreds of dogs are hit with dog flu over the last couple of years. In a new development, this flu strain has hit Florida for the first time. At least a dozen dogs have been down with the virus according to a report issued by the University of Florida's College of Veterinary Medicine on the 31st of May 2017.
Doctors have been given permission to assist two women in becoming pregnant with "three-person" babies for the first time in the UK.
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
› Verified 2 days ago
| Entity Name | Msu Health Care Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700418670 PECOS PAC ID: 8628404936 Enrollment ID: O20200518002744 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
Hundreds of dogs are hit with dog flu over the last couple of years. In a new development, this flu strain has hit Florida for the first time. At least a dozen dogs have been down with the virus according to a report issued by the University of Florida's College of Veterinary Medicine on the 31st of May 2017.
Doctors have been given permission to assist two women in becoming pregnant with "three-person" babies for the first time in the UK.
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan C O'connor, DO 804 Service Rd Ste A109b, East Lansing, MI 48824-7015 Ph: (517) 884-8701 | Ryan C O'connor, DO 4660 S Hagadorn Rd Ste 520, East Lansing, MI 48823-6804 Ph: (517) 884-8701 |
News Archive
Sunshine Biopharma, Inc. a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has executed an agreement with The Jewish General Hospital, one of McGill University's Hospital Centers, to conduct the necessary research and development to advance Sunshine's lead compound, Adva-27a, through the various stages of preclinical studies and Phase I clinical trials.
Hundreds of dogs are hit with dog flu over the last couple of years. In a new development, this flu strain has hit Florida for the first time. At least a dozen dogs have been down with the virus according to a report issued by the University of Florida's College of Veterinary Medicine on the 31st of May 2017.
Doctors have been given permission to assist two women in becoming pregnant with "three-person" babies for the first time in the UK.
NPS Pharmaceuticals, Inc. a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of the 24-week treatment phase of the company's Phase 3 registration study of GATTEX® (teduglutide).
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly 26 million people in the United States alone and counts as one of the leading causes of heart disease, stroke and kidney, eye and nerve damage.
› Verified 2 days ago
Michael T Wheeler, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 250 E Saginaw St, East Lansing, MI 48823 Phone: 517-337-3080 Fax: 517-337-3082 | |
Travis Kiser, AT, ATC Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1720 Abbey Rd Ste A, East Lansing, MI 48823 Phone: 517-333-6692 Fax: 517-333-6705 | |
John David Tegtmeier, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4660 S Hagadorn Rd Ste 520, East Lansing, MI 48823 Phone: 517-884-8701 Fax: 517-884-8787 | |
Dr. Mathew Reza Saffarian, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4660 S Hagadorn Rd Ste 520, East Lansing, MI 48823 Phone: 517-884-8701 Fax: 517-884-8787 | |
Ryan George Topham, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 250 E Saginaw St, East Lansing, MI 48823 Phone: 517-337-3080 Fax: 517-337-3082 | |
Bret Burlingame, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1200 E Michigan Ave, Ste 520, East Lansing, MI 48912 Phone: 517-364-5260 Fax: 517-364-5251 |